Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Juncell Therapeutics Opens New TIL Manufacturing Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

Juncell Therapeutics Opens New TIL Manufacturing Facility

With a total area exceeding 16,000 square meters, the new facility houses the company's production, quality, data, and operation centers.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Shanghai Juncell Therapeutics Co. Ltd., a clinical-stage biotech focused on innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies, has opened its new TIL manufacturing facility located at Anting International Medical Industry Park in Jiading District, Shanghai, China.
 
Juncell Therapeutics’ latest facility, with a total area exceeding 16,000 square meters, houses the company’s production, quality, data, and operation centers. This facility, with a designed production capacity of TIL products for 6,000-10,000 patients annually, represents a significant milestone. The establishment of the facility will significantly promote the development of high-quality TIL products and the transformation of disruptive technologies into new quality productive forces.
 
Officials from National Development and Reform Commission, Shanghai Municipality, Jiading District, Anting Town, and Anting International Medical Industry Park, as well as representatives from various investment institutions, clinical experts, and executives from leading industrial companies, attended the ceremony to witness the grand opening of Juncell’s high-standard TIL manufacturing facility.
 
Dr. Jin Huajun, the founder of Juncell Therapeutics, expressed his heartfelt gratitude to all the leaders and guests present at the ceremony.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics